Goldman Comments on Infoblox's (BLOX) FQ1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Boeing nears approval of 737 MAX anti-ice fix, paving way for deliveries
UBS Upbeat Following Infoblox (BLOX) FQ1
November 29, 2012 1:32 PM ESTFollowing a positive FQ1 earnings report, UBS maintained a Buy rating on Infoblox (NYSE: BLOX) and raised its price target to $25.00 (from $24.00).
Analysts said the company remained one of the more compelling secular growers in the space, and was benefiting from positive industry trends, including... More
Infoblox (BLOX) Tops Q1 EPS by 6c; Boosts FY12 Outlook, Gudes Q2
November 28, 2012 4:13 PM ESTInfoblox (NYSE: BLOX) reported Q1 EPS of $0.06, $0.06 better than the analyst estimate of $0.00. Revenue for the quarter came in at $49.5 million versus the consensus estimate of $46.18 million.
Infoblox sees FY2012 EPS of $0.17-0.21, versus prior guidance of $0.04-0.07 and the consensus of $0.06.... More
